IDH2 and central nervous system cancer: The mean age at diagnosis was 59.1 ± 16.0 years for the IDH-wildtype group and 44.0 ± 11.5 years for the IDH-mutant group, consistent with previous reports showing significantly younger onset in IDH-mutant gliomas [1,7,30].